7.30
+0.31(+4.43%)
Currency In USD
Address
520 Newport Center Drive
Newport Beach, CA 92660
United States of America
Phone
949 284 4555
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
372
First IPO Date
February 08, 2018
| Name | Title | Pay | Year Born |
| Mr. David Moatazedi | President, Chief Executive Officer & Director | 1.67M | 1978 |
| Ms. Tomoko Yamagishi-Dressler | Chief Marketing Officer | 677,374 | 1965 |
| Ms. Sandra Beaver | Chief Financial Officer | 753,208 | 1978 |
| Dr. Rui Avelar C.CFP, Dip.SportMed, M.D. | Chief Medical Officer and Head of Research & Development | 811,076 | 1962 |
| Ms. Jessica Novak | Senior Vice President of Human Resources | 0 | N/A |
| Mr. Jeffrey J. Plumer | General Counsel | 0 | N/A |
| Mr. Nareg Sagherian | Head of Global Investor Relations & Corporate Communications | 0 | N/A |
| Mr. Kurt Knab | Senior Vice President of Sales | 0 | N/A |
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.